Skip to main content

Advertisement

Table 4 The risk of carotid atherosclerotic plaques associated with 1 SD decrease in osteocalcin

From: Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes

  Model PLQ p valuea
Total Model 1 1.93 (1.32-3.01) <0.001
Model 2 1.86 (1.31-2.95) <0.001
Model 3 1.82 (1.28-2.94) <0.001
Model 4 1.81(1.24-2.82) <0.001
Model 5 1.76 (1.22-2.77) 0.005
men Model 1 2.13 (1.41-3.69) <0.001
Model 2 2.02 (1.50-3.57) <0.001
Model 3 1.91 (1.32-2.88) <0.001
Model 4 1.83(1.27-2.85) <0.001
Model 5 1.81 (1.25-2.83) <0.001
women Model 1 1.88 (1.29-3.12) <0.001
Model 2 1.84 (1.27-2.99) <0.001
Model 3 1.80 (1.24-2.98) <0.001
Model 4 1.79(1.22-2.92) <0.001
  Model 5 1.75 (1.19-2.85) 0.008
  1. Values are ORs (95% CI).
  2. Model 1: Unadjusted. Model 2: Adjusted for age, sex, smoking (yes/no), alcohol drinking (yes/no), family history of diabetes (yes/no). Model 3: Further adjusted for waist circumference, HOMA-IR, BMI and waist/hip ratio. Model 4: Further adjusted for serum triacylglycerol, total cholesterol, HDL- and LDL-cholesterol. Model 5: Further adjusted for inflammatory factors (CRP) and treatments (including antihypertensive therapy, antihyperlipidemic therapy and antihyperglycemic therapy). aFor the risk of PLQ, we defined subjects with no carotid atherosclerotic plaques as 0, and carotid atherosclerotic plaques as 1 from the analysis.